THP
BLFS icon

Tower House Partners’s BioLife Solutions BLFS Stock Holding History

Tower House Partners’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-304,493
Closed -$11M – 6
2021
Q1 		$11M Sell
304,493
-168,607
-36% -$6.67M 5.34% 6
2020
Q4 		$18.9M Buy
+473,100
New +$16.1M 9.2% 5

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tower House Partners's BLFS Position: Q2 2021 in Review

Tower House Partners sold out of BioLife Solutions (BLFS) in Q2 2021, closing a stake of 304,493 shares — an estimated $11M sold.

Tower House Partners first reported a position in BLFS in Q4 2020 and held it in 2 quarters. The position peaked at $18.9M in Q4 2020. 132 funds tracked by Wall St. Rank hold BLFS as of Q2 2021.

  • Tower House Partners reported no remaining BioLife Solutions position as of Q2 2021 after selling out during the quarter.
  • Tower House Partners sold 304,493 BioLife Solutions shares in Q2 2021, an estimated $11M.
  • Tower House Partners first reported a position in BioLife Solutions in Q4 2020 and held it in 2 quarters.
  • Tower House Partners's BioLife Solutions position peaked at $18.9M in Q4 2020.
  • 132 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2021.

Based on Tower House Partners's 13F filing for Q2 2021, filed 17 Aug 2021.